 |
PDBsum entry 3mvl
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-Methylphenylamino)-5-Methyl-N-Propylpyrrolo[1,2-F][1,2,4]triazine-6-Carboxamide (bms-582949), A clinical p38α map kinase inhibitor for the treatment of inflammatory diseases.
|
 |
|
Authors
|
 |
C.Liu,
J.Lin,
S.T.Wrobleski,
S.Lin,
J.Hynes,
H.Wu,
A.J.Dyckman,
T.Li,
J.Wityak,
K.M.Gillooly,
S.Pitt,
D.R.Shen,
R.F.Zhang,
K.W.Mcintyre,
L.Salter-Cid,
D.J.Shuster,
H.Zhang,
P.H.Marathe,
A.M.Doweyko,
J.S.Sack,
S.E.Kiefer,
K.F.Kish,
J.A.Newitt,
M.Mckinnon,
J.H.Dodd,
J.C.Barrish,
G.L.Schieven,
K.Leftheris.
|
 |
|
Ref.
|
 |
J Med Chem, 2010,
53,
6629-6639.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
No abstract given.
|
 |
|
|
|
|
 |